Merck KGaA (MKGAY) News Today

→ REVEALED: Elon Musk’s Secret A.I. Facility? (From InvestorPlace) (Ad)

$38.36

0.00 (0.00%)

(As of 08/1/2017)

Stock Analysis

Source

Source	Headline
	Merck Highlights Data From Multiple Phase 3 Trials For Its Investigational Pneumococcal Conjugate Vaccine msn.com - March 19 at 4:30 PM
	Future Scientists in the Making: MilliporeSigma's Curiosity Cube Wraps Up 2023 Multi-Country STEM Tour finanznachrichten.de - February 8 at 11:17 AM
	Merck KGaA wsj.com - January 22 at 6:18 PM
	Merck KGaA ADR MRKC morningstar.com - January 3 at 12:21 AM
	Merck KGaA Q3 Results Down; Now Sees FY23 Earnings In Lower Half Of Estimate Range markets.businessinsider.com - November 9 at 9:53 AM
	How This New Merck Regimen Could 'Rewrite Textbooks' In Cancer Treatment — And Bolster 4 Stocks msn.com - October 22 at 2:40 PM
	FDA grants expanded approval for Merck's lung cancer drug Keytruda msn.com - October 17 at 12:11 AM
	EC Approves Merck's KEYTRUDA As Adjuvant Treatment For Non-Small Cell Lung Cancer markets.businessinsider.com - October 16 at 9:10 AM
	Merck's Lead Cancer Drug Meets Primary Goal In Certain Type Of Lung Cancer Patients msn.com - October 10 at 2:47 PM
	Merck's blood vessel disorder therapy receives US FDA's priority review reuters.com - September 28 at 7:29 AM
	Merck and ICR enter renewed cancer drug discovery partnership msn.com - September 25 at 9:42 AM
	Exscientia, Merck KGaA To Discover Drug Candidates Across Oncology, Neuroinflammation & Immunology markets.businessinsider.com - September 20 at 1:33 AM
	Merck KGaA reports Q2 results msn.com - August 3 at 2:06 PM
	Merck KGaA Q2 Results Down, Cuts FY23 View; Backs FY25 Outlook markets.businessinsider.com - August 3 at 8:59 AM
	Global Cell and Gene Therapy Manufacturing Services Market to 2028, Led by Catalent, Lonza, Merck KGaA, and Thermo Fisher Scientific finance.yahoo.com - August 1 at 6:23 PM
	Merck Releases Encouraging Data From Two Late-Stage Studies For Pneumococcal Conjugate Vaccine benzinga.com - July 27 at 9:35 PM
	Moderna/Merck begin late-stage study of mRNA cancer vaccine msn.com - July 27 at 3:05 AM
	Barclays Maintains Merck (MRK) Overweight Recommendation msn.com - May 1 at 2:29 PM
	Merck Makes a Bold Move That Could Transform Its Business msn.com - April 27 at 1:37 PM
	Merck: Q1 Earnings Snapshot washingtonpost.com - April 27 at 8:36 AM
	Merck Gains on Q1 Beat msn.com - April 27 at 8:36 AM
	Merck Keeps Striking Out on Expanding Its Cancer-Drug Juggernaut msn.com - April 26 at 10:15 AM
	Merck KGaA Shares Fall After US Puts Hold on New Patients in MS Drug Trial wsj.com - April 12 at 10:03 AM
	Merck (MRK) Keytruda Studies in Difficult-to-Treat Cancers Fail msn.com - April 10 at 2:51 PM
	Merck, Eisai end two Keytruda combination trials after missing main goals msn.com - April 7 at 3:10 PM
	Merck KGaA Realigns Research Activities in Healthcare Unit marketwatch.com - March 31 at 10:10 AM
	Merck Keytruda, anti-TIGIT therapy coformulation hits setback in mid-stage trial seekingalpha.com - March 19 at 5:41 PM
	Merck Highlights Promising Data From Two Candidates In Heart Diseases finance.yahoo.com - March 17 at 12:38 AM
	Merck's MK-0616, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Patients with Hypercholesterolemia in Phase 2b Study benzinga.com - March 6 at 4:11 PM
	Merck's MK-0616 Cuts LDL-C in Hypercholesterolemia in Phase 2b Study >MRK marketwatch.com - March 6 at 4:11 PM
	Merck KGaA Shares Fall After Warning of Challenges Ahead marketwatch.com - March 4 at 8:46 PM
	Merck KGaA shares slip after group warns of decline in 2023 profit investing.com - March 2 at 4:14 AM
	Merck KgaA FY22 Profit Rises, Lifts Dividend; Sees Organic Sales Growth In FY23; Backs FY25 View markets.businessinsider.com - March 2 at 3:04 AM
	Here's How Much $1000 Invested In Merck & Co 5 Years Ago Would Be Worth Today benzinga.com - March 1 at 10:04 PM
	Merck to discontinue Keytruda combination study for prostate cancer reuters.com - February 28 at 7:50 AM
	European committee: Regulators should deny Merck's Lagevrio sfgate.com - February 26 at 2:25 PM
	EU regulator recommends against approval for Merck's COVID pill for adults reuters.com - February 26 at 2:25 PM
	Merck Says Keytruda/Chemo Combo Improved Overall Survival Compared To Chemo Alone In Gastric Cancer Settings finance.yahoo.com - February 24 at 7:01 AM
	Merck under lawmakers' scrutiny over Keytruda patents msn.com - February 23 at 3:59 PM
	Dow's 60-point jump led by gains for Amgen, Merck stocks msn.com - February 19 at 2:20 PM
	Bears are Losing Control Over Merck KGaA (MKGAF), Here's Why It's a 'Buy' Now nasdaq.com - February 9 at 11:24 AM
	Merck Q4 results in focus with eye on future beyond Keytruda msn.com - February 1 at 7:10 PM
	Merck Animal Health: FDA Approves Expanded Indication For BRAVECTO Chews For Dogs markets.businessinsider.com - January 26 at 3:08 PM
	Merck: Getting Less Attractive seekingalpha.com - January 22 at 1:42 AM
	Merck Is A Strong Investment Opportunity For Long-Term Growth seekingalpha.com - January 21 at 8:42 PM
	Merck and the "Holy Grail" finance.yahoo.com - January 18 at 8:14 PM
	PDS Biotech, Merck Germany Enter Licensing Pact For Investigational Cancer Treatment msn.com - January 3 at 1:43 PM
	Merck (MRK) Inks Deal to Develop Antibodies for Treating Cancer msn.com - December 23 at 1:19 PM
	Mersana signs deal with Merck KGaA for cancer therapy development investing.com - December 22 at 4:28 PM
	Merck leans on new Keytruda formulation to avoid patent cliff seekingalpha.com - December 3 at 12:50 AM

Get Merck KGaA News Delivered to You Automatically

“Forget Tesla, this is Elon’s Next Big Thing” (Ad)

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

Click here to see the details.

MKGAY Media Mentions By Week

MKGAY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MKGAY
News Sentiment
▼
0.00

0.66
▲
Average
Medical
News Sentiment

MKGAY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MKGAY Articles
This Week
▼
0

0
▲
MKGAY Articles
Average Week

Get Merck KGaA News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (OTCMKTS:MKGAY) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Merck KGaA (MKGAY) News Today

MKGAY Media Mentions By Week

MKGAY Media Sentiment

MKGAY News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info